Under s-μg, the prostatic carcinoma TSU-PR1 cell line, derived from a lymph node metastatic prostate adenocarcinoma and characterized by a low PAP level, was able to invade benign prostate tissue. This evidence concerns the gene ACP3 and prostate carcinoma.